| Literature DB >> 29284416 |
Gizat M Kassie1, Tuan A Nguyen2, Lisa M Kalisch Ellett2, Nicole L Pratt2, Elizabeth E Roughead2.
Abstract
BACKGROUND: Medications are frequently reported as both predisposing factors and inducers of delirium. This review evaluated the available evidence and determined the magnitude of risk of postoperative delirium associated with preoperative medication use.Entities:
Keywords: Adverse drug event; Delirium; Elderly; Medication; Medication related problem; Medication safety; Prevention; Risk factor
Mesh:
Substances:
Year: 2017 PMID: 29284416 PMCID: PMC5747155 DOI: 10.1186/s12877-017-0695-x
Source DB: PubMed Journal: BMC Geriatr ISSN: 1471-2318 Impact factor: 3.921
Fig. 1Flowchart of study selection and inclusion
Characteristics of studies included in the systematic review by type of surgery
| Study (First Author, Publication year, Country) | Year of data collection | N | Age, Mean (SD) | Sex, Male (%) | Type of surgery | Diagnostic tool | Delirium incidence (%) | Study quality (star)a |
|---|---|---|---|---|---|---|---|---|
| Juliebo, 2009, Norway [ | 2005–2006 | 187 | 84.0b (79–88)c | 24 | Orthopaedic | CAM | 36 | 7 |
| Kudoh, 2004, Japan [ | NR | 328 | 73.2 | 2 | Orthopaedic | CAM | 15 | 7 |
| Muangpaisan, 2015, Thailand [ | 2010–2012 | 80 | 79.4 (7.9) | 25 | Hip fracture | CAM | 45 | 7 |
| Goldenberg, 2006, USA [ | 2000–2002 | 77 | 81.9 (7.5) | 35 | Hip fracture | CAM | 48 | 7 |
| Galanakis, 2001, Germany [ | 1998 | 105 | 74.9b (60–98)d | 29 | Hip surgery | CAM | 24 | 9 |
| Duppils, 1999, Sweden [ | 1996–1997 | 225 | 85.4 | 33 | Hip surgery | DSM-IV | 20 | 6 |
| Schuurmans, 2003, Netherlands [ | 1998–1999 | 92 | 82.7 (6.7) | 13 | Hip fracture | DSM-IV | 20 | 7 |
| Huang, 2017, Singapore [ | 2006 | 954 | 78be, 67 bf | 81 | Total knee arthroplasty | DSM-IV | 1 | 7 |
| Mariscalco, 2012, Italy [ | 2004–2010 | 4659 | 67.8 (9.2) | 79 | Coronary revascularization | CAM-ICU | 3 | 9 |
| Afonso, 2010, USA [ | 2008 | 112 | 66 (19–84)d | 57 | Cardiac and thoracic aortic | CAM-ICU | 34 | 7 |
| Burkhart, 2010, Switzerland [ | NR | 113 | 74.3 (5.5) | 68 | Cardiopulmonary bypass | CAM | 30 | 7 |
| Santos, 2004, Brazil [ | 1996–1999 | 220 | 70.7 | 65 | Coronary artery bypass graft | CAM-ICU | 34 | 8 |
| Rudolph, 2008, USA [ | NR | 42 | 68.1 | 83 | Cardiac | CAM | 29 | 8 |
| Tan, 2008, USA [ | 2006 | 53 | 62.7 | 100 | Cardiac | MDAS | 23 | 6 |
| Veliz-Reissmuller, 2007, Sweden [ | NR | 107 | 72.9 (5.4) | 62 | Elective cardiac | CAM | 23 | 7 |
| Katznelson, 2009b, Canada [ | 2006–2007 | 582 | 67.9 | 71 | Elective and emergency vascular | NEECHAM | 22 | 9 |
| Van Der Mast, 1999, Netherlands [ | NR | 296 | 63.0 (11) | 65 | Elective cardiac | DSM-III-R | 14 | 7 |
| Katznelson, 2009c, Canada [ | 2005–2006 | 1059 | 63.6g | 71 | Cardiopulmonary bypass | CAM-ICU | 12 | 9 |
| Tully, 2010, Australia [ | 2007–2009 | 158 | 64.7 (10.6) | 79 | Coronary artery bypass graft | DSI | 31 | 8 |
| Benoit, 2005, Canada [ | 2000–2003 | 102 | 70.8 (8.2) | 77 | Elective abdominal aortic aneurysm | CAM | 33 | 7 |
| Tognoni, 2011, Italy [ | NR | 90 | 74.3 (0.40) | 90 | Urologic | CAM | 9 | 7 |
| Dai, 2000, Taiwan [ | 1995–1997 | 701 | 72.7 (6.3) | 46 | Elective orthopaedic and urologic | DSM-IV | 5 | 7 |
| Chen, 2015, Taiwan [ | 2009–2013 | 401 | 61.2 (11.2) | 74 | Hepatectomy for HCC | CAM | 8 | 7 |
| Jeong, 2016, Korea [ | 2014–2015 | 475 | 76.0b(65–96)d | 45 | Cancer surgery | DSM-IV | 4 | 8 |
| Brouquet, 2010, France [ | 2006–2008 | 118 | 81.3 (4.8) | 48 | Elective major abdominal | CAM | 24 | 8 |
| Behrends, 2013, USA [ | 2003–2011 | 472 | 38.1h | 52 | Major non-cardiac | CAM | 29 | 7 |
| Litaker, 2001, USA [ | NR | 500 | 67.0 (9.0) | NR | Elective major surgery | CAM | 11 | 8 |
| Xue, 2016, China [ | 2010–2015 | 358 | 75.1 | NR | Transurethral resection of prostate | CAM | 8 | 8 |
| Brown, 2016, USA [ | 2012–2014 | 89 | 74b | 53 | Spine surgery | CAM/CAM-ICU | 41 | 9 |
NR not reported, SD standard deviation, DSI delirium symptom interview, DSM diagnostic and statistical manual for mental disorders, DOS delirium observation screening, MDAS memorial delirium assessment scale, NEECHAM neelon and champagne confusion scale, HCC Hepatocellular carcinoma
aStudy quality assessment as per NOS; bMedian; cInterquartile range; dRange; edelirium group; fnon-delirium group; g63.6% were > 60 years old; h38.1% were > 75 years
Studies designed to investigate the effect of preoperative use of specific medicines on postoperative delirium
| Study (First author, publication year) | Preoperative medicines | Other covariates | OR or RR (95% CI)c |
|
|---|---|---|---|---|
| Katznelson, 2009b [ | Beta-blockers | Age | OR 2.06 (1.18–3.60) | 0.011 |
| Statinsa | OR 0.56 (0.37–0.88) | 0.011 | ||
| Katznelson, 2009c [ | Statinsa | Older age | OR 0.54 (0.35–0.84) | 0.010 |
| Mariscalco, 2012 [ | Statinsb | Age group | OR 1.52 (0.97–2.37) | 0.180 |
| Kudoh, 2004 [ | Benzodiazepines | Preoperative Mini-Mental State scores, anxiety | RR 2.10 (1.23–3.59) | 0.007 |
CI confidence interval, OR odds ratio, RR relative risk; a Protective effect; b Not associate; c only for preoperative medicines
Associations between preoperative medications and postoperative delirium reported in multivariate analyses of risk factor studies
| Study (First author, publication year) | Preoperative medicines | Other covariates | Number of study participants | Number of patients with medications | OR or RR (95% CI)e |
|
|---|---|---|---|---|---|---|
| Chen, 2015 [ | Hypnotics | Advanced age | 401 | 42 | OR 3.07 (1.05–9.04) | 0.041 |
| Galanakis, 2001 [ | Hypnotics and sedatives | Age | 105 | 21 | OR 2.53 (0.79–8.04) | NS |
| Benoit, 2005 [ | Psychoactive medicines | Lower education level | 102 | 0.18a (0.4c), 0.5b (0.8c) | OR 6.80d | 0.005 |
| Xue, 2016 [ | Psychoactive medicines | Old age | 358 | 64 | OR 1.60 (0.65–3.93) | 0.306 |
| Duppils, 2000 [ | Psychopharmacological drugs | Older age | 225 | 88 | OR 2.92 (1.33–6.39) | 0.007 |
| Dai, 2000 [ | Narcotics and other | Age | 701 | 1.0a (0.8c), 1.7b (0.9c) | RR 6.56 (1.53–28.17) | < 0.05 |
| Litaker, 2001 [ | Narcotics | Previous delirium | 500 | 87 | OR 2.70 (1.4–5.3) | Sig |
| Behrends, 2013 [ | Narcotics | Age | 472 | 333 | OR 1.02 (0.61–1.70) | 0.940 |
| Tully, 2010 [ | Anticholinergic, selective serotonin re-uptake inhibitor and tricyclic drug | Major depression | 158 | 12 | OR 6.17 (1.27–30.12) | 0.020 |
| Tan, 2008 USA [ | ‘other’ anticholinergic medications | History of cerebrovascular disease | 53 | 20 | RR 2.31 (0.85–6.31) | 0.100 |
| Brown, 2016 [ | Antidepressant | Lower baseline cognition | 89 | 26 | OR 4.70 (1.03–21.5) | 0.046 |
| Benoit, 2005 [ | Antihypertensive and antianginals | Lower education level | 102 | 0.8a (0.8c), 0.4b (0.5c) | OR 0.26d | 0.016 |
| Van Der Mast, 1999 [ | Nifedipine | Old age | 296 | 53 | OR 2.40 (1.0–5.8) | 0.047 |
| Jeong, 2016 [ | DIM | Dementia | 475 | 200 | OR 12.8(2.8–57.7) | < 0.001 |
CI confidence interval, OR odds ratio, RR relative risk, Sig reported as significant, NS reported as not significant, DIM medications whose adverse events, such as delirium, confusion or hallucination, were reported over 1% by the drug information database Micromedex®
aAverage number of medicines in the non-delirium group; bAverage number of medicines in the delirium group; cStandard deviation; dCI not reported or data not sufficient to calculate; eonly for preoperative medicines